Abivax |
Biotechnology · Immunology & Inflammation Therapeutics
Has an LEI
20–49EmployeesFrench register · Dec 2023 ↗
Data updated Nov 20, 2026Full reportReport a mistake
Lately:7 news stories in 90 daysFollow changes →
Facts
as of Nov 20, 2026Abivax is a clinical-stage biotechnology company driven to advance human health by regulating the immune response through the power of microRNA.
- Legal name
- ABIVAXactive
- Headquarters
- Paris, France
- Founded
- 2013
- Employees
- 20–49French register · Dec 2023
- Register numbers
- SIREN 799363718
- Official records
- Wikidata Q30268737LEI 969500D8TMNB184OJU95
- Website
- abivax.com
These are the key facts about Abivax | on Alion as of Nov 20, 2026. Abivax | is headquartered in Paris, France. It was founded in 2013.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
People
20–49EmployeesFrench register · Dec 2023
Products
Risk
Full record →Abivax |: 33 research papers in five years.
Yes
No match
None
None
Patents
35
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Milestones
Increased its share capital $679k · BODACC
Dec 1, 2023
Increased its share capital $457k · BODACC
Mar 31, 2023
Increased its share capital $241k · BODACC
Sep 30, 2022
Increased its share capital $104k · BODACC
Aug 20, 2015
Newsroom
Sep 26
Press releaseThe Globe and Mail
Sep 23
NewsPulse 2.0
Sep 23
Sources: the outlets named on each headline, each story once
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Paris France | Headquarters | 0 |
Source: office addresses in postings and company registers
